NEW YORK (GenomeWeb News) – Nanotechnology company NanoPacific Holdings said this week that it has exclusively licensed a suite of supramolecular nanoparticle technologies from the University of California at Los Angeles.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.
A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.
As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.
In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.